Shares of ADEA are declining approximately 12.00% on Tuesday, May 5, 2026, in a post-earnings market reaction as the company's Q1 2026 results — released after Monday's market close — delivered an EPS beat of $0.38 versus the $0.36 consensus

Shares of INSP are plunging approximately 14.00% on Tuesday, May 5, 2026, falling from a prior close of $54.84 to approximately $47.17 — a new 52-week low — as Q1 2026 results released after Monday's market close delivered a meaningful revenue beat that was immediately overshadowed by a severe full-year 2026 revenue guidance cut from approximately $900–$920 million to $825–$875 million,

Shares of PCOR are declining approximately 11.00% on Tuesday, May 5, 2026, falling from a prior close of approximately $62.10 to approximately $55.24 — a significant earnings-driven selloff despite Q1 2026 results that beat analyst consensus on both revenue and EPS — as a "sell the news" dynamic unfolds following the stock's nearly 25% pre-earnings rally from its February 52-week low of $49.39, leaving valuation expectations elevated in a way that a solid beat alone cannot sustain.

ACN stock declined approximately -9% over the past 30 days amid sector-wide concerns in IT consulting, trading near 52-week lows around $180. Over the past quarter, shares fell about -23%, driven by fears of AI disruption, federal contract delays, and softer guidance despite solid Q2 earnings.

TXN stock surged +43% over the last 30 days, propelled by a strong Q1 earnings beat and upbeat guidance, alongside explosive data center demand. Over the past quarter, shares climbed +25%, reflecting broader semiconductor recovery and AI-driven momentum in analog chips.

ABT stock declined approximately -14% over the past 30 days, driven primarily by a post-earnings sell-off following Q1 results and lowered full-year profit guidance due to the Exact Sciences acquisition. Over the past quarter, the stock fell around -20%, reflecting broader pressures from weaker nutrition and diagnostics segments amid a challenging respiratory season.

LRCX stock surged +24% over the last 30 days, driven primarily by a strong Q3 fiscal 2026 earnings beat with revenue up 24% year-over-year to $5.84 billion and adjusted EPS of $1.47, exceeding estimates. Over the past quarter, the stock rose +22%, reflecting sustained AI-driven demand for semiconductor manufacturing equipment amid robust wafer fabrication equipment (WFE) spending forecasts.

OSIS shares plunged 15.36% to close at $239.59 from the previous close of $282.87 in the most recent completed trading session. Primary catalyst: Post-earnings sell-off despite beating Q3 estimates, driven by concerns over timing headwinds, unchanged full-year guidance, and management warnings on Mexico contracts, DHS shutdown, Middle East conflicts, and supply chain issues.

ADTN shares plunged 17.25% in the latest session, closing at $15.18 after the prior close of $18.34. Primary catalyst: Market reaction to Q1 2026 earnings released after market close on May 4, with non-GAAP EPS of $0.14 beating estimates of $0.09, but GAAP loss of $0.01 per share and ongoing cost pressures.

BellRing Brands ( BRBR ) shares plunged 43.09% to $9.88 in the most recent trading session. The primary catalyst was a disappointing Q2 fiscal 2026 earnings report, with adjusted EPS of $0.14 missing estimates of $0.31 by 55% and revenue of $598.7 million falling short of $608.8 million expectations.

Shopify (SHOP) shares plunged 10.25% to close at $114.48 from the previous close of $127.55. Primary catalyst: Disappointing Q2 revenue guidance overshadowed a Q1 earnings beat with 34% revenue growth to $3.17 billion and strong gross merchandise volume (GMV) of $100.7 billion.

PLTR shares declined 5.89% to $137.43 during today's trading session, following a close of $146.03 on the prior session. Primary catalyst: Investor disappointment over a slight miss in U.

GeneDx Holdings ( WGS ) shares plunged 48.54% to close at $34.95, following the previous close of $67.93. Primary catalyst: Q1 2026 earnings miss with EPS of -$0.28 versus expected -$0.06, and revenue of $102.3 million missing consensus of $112.5 million.

IPGP shares plunged 26.51% to $89.89 in early trading on May 5, 2026, following Q1 earnings release before the market open. Q1 revenue beat estimates at $265.5 million, up 17% year-over-year, driven by industrial solutions demand.

Aptiv PLC ( APTV ) shares plunged 11.36% to 52.77 during Monday's session. The sell-off followed Q1 2026 earnings that beat estimates with adjusted EPS of $1.71 versus $1.58 expected and revenue of $5.1 billion up 5% year-over-year.

PYPL shares plunged 10.65% to $45.02 in early trading on May 5, 2026, from the previous close of $50.39. Primary catalyst: Q1 2026 earnings beat estimates with non-GAAP EPS of $1.34 (vs.

Novo Nordisk is scheduled to report Q1 2026 results on May 6, 2026, before market open. Analysts expect EPS of $0.87, down about 5% year-over-year from Q1 2025's $0.92.

Analysts expect Q2 fiscal 2026 EPS of $1.50, up 3.4% from $1.45 in the year-ago quarter. Revenue consensus stands at $24.83 billion, reflecting 5.1% year-over-year growth.

Analysts expect Q4 FY2026 revenue of $1.47 billion, aligning with company guidance midpoint and implying 18% year-over-year growth. Consensus non-GAAP EPS forecast stands at $0.58, matching Arm Holdings' guidance and up from $0.55 in the prior-year quarter.

Analysts expect Q1 2026 EPS of C$1.93, a 47% increase from C$1.31 in Q1 2025. Consensus revenue forecast stands at C$13.91 billion, up from C$12.45 billion year-over-year.